Valiant Organics Ltd (VALIANTORG) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002678,
    "name": "Valiant Organics",
    "stock_name": "Valiant Organics",
    "full_name": "Valiant Organics Ltd",
    "name_url": "stocks-analysis/valiant-organics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "240.20",
    "chg": 0.7,
    "chgp": "0.29%",
    "dir": 1,
    "prev_price": "239.50",
    "mcapval": "695.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540145,
    "symbol": "VALIANTORG",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE565V01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "41.07 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/valiant-organics-1002678-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-upper-circuit-amid-strong-buying-pressure-3746734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_stocks_hitting_upper_circuit_3746734.png",
        "date": "2025-12-04 12:00:09",
        "description": "Valiant Organics Ltd witnessed robust buying interest on 4 December 2025, with its stock price hitting the upper circuit limit of ₹268.10, marking a maximum daily gain of 4.99%. This surge outpaced the Specialty Chemicals sector and broader market indices, reflecting heightened investor enthusiasm despite a recent period of subdued activity."
      },
      {
        "title": "Valiant Organics Surges with Unprecedented Buying Interest, Edging Towards Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-surges-to-upper-circuit-on-unprecedented-buying-interest-3746704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_only_buyers_3746704.png",
        "date": "2025-12-04 11:40:50",
        "description": "Valiant Organics Ltd has witnessed extraordinary buying momentum today, registering a 5.00% gain and hitting an intraday high of Rs 268.85. The stock’s performance stands in stark contrast to the broader market, with the Sensex advancing a modest 0.23%, underscoring a rare scenario where only buy orders populate the order book, signalling potential for a sustained multi-day upper circuit."
      },
      {
        "title": "Valiant Organics Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-technical-momentum-shifts-amid-bearish-sentiment-3740303",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_technicaldot_3740303.png",
        "date": "2025-12-02 08:10:48",
        "description": "Valiant Organics, a key player in the Specialty Chemicals sector, has experienced notable shifts in its technical momentum as recent market assessments reveal a transition from bearish to mildly bearish trends. This article analyses the evolving technical indicators, price movements, and comparative returns to provide a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-upper-circuit-amid-strong-buying-pressure-3738673",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_stocks_hitting_upper_circuit_3738673.png",
        "date": "2025-12-01 12:00:09",
        "description": "Valiant Organics Ltd, a micro-cap player in the specialty chemicals sector, witnessed robust buying interest on 1 Dec 2025, hitting its upper circuit limit with a 5.0% gain to close at ₹264.80. The stock outperformed its sector and broader market indices, reflecting heightened investor enthusiasm despite a backdrop of subdued delivery volumes and mixed moving average signals."
      },
      {
        "title": "Valiant Organics Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-organics-downgraded-to-sell-by-marketsmojo-amid-weak-financial-trends-3737996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_mojoScore_3737996.png",
        "date": "2025-12-01 10:09:27",
        "description": "Valiant Organics, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance on its near-term prospects."
      },
      {
        "title": "Why is Valiant Organics falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-valiant-organics-fallingrising-3729931",
        "imagepath": "",
        "date": "2025-11-26 01:17:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend and Market Underperformance</strong></p>\n<p>Valiant Organics closed at ₹252.90, down ₹4.15 or 1.61% as of 08:54 PM on 25-Nov. This decline is part of a broader negative trend, with the stock having fallen by 10.59% over the past week, significantly underperforming the Sensex, which was nearly flat with a marginal 0.10% gain during the same period. The one-month performance paints a similar picture, with Valiant Organics dropping 17.15% while the Sensex gained 0.45%. Year-to-date, the stock has declined by 17.08%, contrasting sharply with the Sensex’s 8.25% rise. Over longer horizons, the disparity is even more pronounced, with the stock down 25.40% in one year and a staggering 83.72% over five years, while the Sensex has delivered positive returns of 5.59% and 93.00% res..."
      },
      {
        "title": "Valiant Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-lower-circuit-amid-heavy-selling-pressure-3717598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantOrganics_stocks_hitting_lower_circuit_3717598.png",
        "date": "2025-11-20 10:00:17",
        "description": "Valiant Organics Ltd, a micro-cap player in the Specialty Chemicals sector, witnessed a sharp decline on 20 Nov 2025 as its stock hit the lower circuit price limit, reflecting intense selling pressure and a significant intraday loss. The stock’s performance underperformed its sector peers and broader market indices, signalling a period of heightened volatility and investor caution."
      },
      {
        "title": "Is Valiant Organics overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-valiant-organics-overvalued-or-undervalued-3709985",
        "imagepath": "",
        "date": "2025-11-18 08:26:13",
        "description": "As of 17 November 2025, the valuation grade for Valiant Organics has moved from very attractive to attractive, indicating a shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 33.75, an EV to EBITDA of 12.54, and a PEG ratio of 0.20, which suggests that while the company may have growth potential, its current price does not adequately reflect that potential compared to its earnings.\n\nIn comparison to its peers, Valiant Organics' PE ratio is higher than Cipla's 22.81 but lower than Sun Pharma's 36.69, indicating that while it is relatively attractive within its segment, it still faces pressure from higher-valued competitors. Additionally, its ROCE of 4.56% and ROE of 3.18% are lower than those of many peers, which further supports the overvaluation verdict. Recent stock performance has lagged behind the Sensex, with a YTD return of -7.03% compared to..."
      },
      {
        "title": "Valiant Organics Q2 FY26: Profit Recovery Masks Underlying Revenue Weakness",
        "link": "https://www.marketsmojo.com/news/result-analysis/valiant-organics-q2-fy26-profit-recovery-masks-underlying-revenue-weakness-3718275",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantOrganics_quaterlyResult_3718275.png",
        "date": "2025-11-15 10:54:52",
        "description": "Valiant Organics Ltd., a specialty chemicals manufacturer focused on agro intermediates and pharma applications, reported a consolidated net profit of ₹5.67 crores for Q2 FY26, marking a sharp turnaround from the ₹12.78 crore loss recorded in the same quarter last year. However, the recovery came amidst a concerning 23.04% sequential revenue decline, raising questions about the sustainability of the company's operational momentum. The stock, trading at ₹285.90 with a market capitalisation of ₹807.00 crores, has declined 19.97% over the past year, significantly underperforming both the Sensex and its specialty chemicals peer group."
      }
    ],
    "total": 240,
    "sid": "1002678",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/valiant-organics-1002678"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Kindly refer to our attached intimation",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "29-Nov-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Organics Ltd has declared <strong>10%</strong> dividend, ex-date: 10 Feb 23",
          "dt": "2023-02-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Organics Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Dec 20",
          "dt": "2020-12-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure

2025-12-04 12:00:09

Valiant Organics Ltd witnessed robust buying interest on 4 December 2025, with its stock price hitting the upper circuit limit of ₹268.10, marking a maximum daily gain of 4.99%. This surge outpaced the Specialty Chemicals sector and broader market indices, reflecting heightened investor enthusiasm despite a recent period of subdued activity.

Valiant Organics Surges with Unprecedented Buying Interest, Edging Towards Multi-Day Upper Circuit

2025-12-04 11:40:50

Valiant Organics Ltd has witnessed extraordinary buying momentum today, registering a 5.00% gain and hitting an intraday high of Rs 268.85. The stock’s performance stands in stark contrast to the broader market, with the Sensex advancing a modest 0.23%, underscoring a rare scenario where only buy orders populate the order book, signalling potential for a sustained multi-day upper circuit.

Valiant Organics Technical Momentum Shifts Amid Market Challenges

2025-12-02 08:10:48

Valiant Organics, a key player in the Specialty Chemicals sector, has experienced notable shifts in its technical momentum as recent market assessments reveal a transition from bearish to mildly bearish trends. This article analyses the evolving technical indicators, price movements, and comparative returns to provide a comprehensive view of the stock’s current positioning.

Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure

2025-12-01 12:00:09

Valiant Organics Ltd, a micro-cap player in the specialty chemicals sector, witnessed robust buying interest on 1 Dec 2025, hitting its upper circuit limit with a 5.0% gain to close at ₹264.80. The stock outperformed its sector and broader market indices, reflecting heightened investor enthusiasm despite a backdrop of subdued delivery volumes and mixed moving average signals.

Valiant Organics Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges

2025-12-01 10:09:27

Valiant Organics, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance on its near-term prospects.

Why is Valiant Organics falling/rising?

2025-11-26 01:17:15

Persistent Downtrend and Market Underperformance Valiant Organics closed at ₹252.90, down ₹4.15 or 1.61% as of 08:54 PM on 25-Nov. This decline is part of a broader negative trend, with the stock having fallen by 10.59% over the past week, significantly underperforming the Sensex, which was nearly flat with a marginal 0.10% gain during the same period. The one-month performance paints a similar picture, with Valiant Organics dropping 17.15% while the Sensex gained 0.45%. Year-to-date, the stock has declined by 17.08%, contrasting sharply with the Sensex’s 8.25% rise. Over longer horizons, the disparity is even more pronounced, with the stock down 25.40% in one year and a staggering 83.72% over five years, while the Sensex has delivered positive returns of 5.59% and 93.00% res...

Valiant Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-11-20 10:00:17

Valiant Organics Ltd, a micro-cap player in the Specialty Chemicals sector, witnessed a sharp decline on 20 Nov 2025 as its stock hit the lower circuit price limit, reflecting intense selling pressure and a significant intraday loss. The stock’s performance underperformed its sector peers and broader market indices, signalling a period of heightened volatility and investor caution.

Is Valiant Organics overvalued or undervalued?

2025-11-18 08:26:13

As of 17 November 2025, the valuation grade for Valiant Organics has moved from very attractive to attractive, indicating a shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 33.75, an EV to EBITDA of 12.54, and a PEG ratio of 0.20, which suggests that while the company may have growth potential, its current price does not adequately reflect that potential compared to its earnings. In comparison to its peers, Valiant Organics' PE ratio is higher than Cipla's 22.81 but lower than Sun Pharma's 36.69, indicating that while it is relatively attractive within its segment, it still faces pressure from higher-valued competitors. Additionally, its ROCE of 4.56% and ROE of 3.18% are lower than those of many peers, which further supports the overvaluation verdict. Recent stock performance has lagged behind the Sensex, with a YTD return of -7.03% compared to...

Valiant Organics Q2 FY26: Profit Recovery Masks Underlying Revenue Weakness

2025-11-15 10:54:52

Valiant Organics Ltd., a specialty chemicals manufacturer focused on agro intermediates and pharma applications, reported a consolidated net profit of ₹5.67 crores for Q2 FY26, marking a sharp turnaround from the ₹12.78 crore loss recorded in the same quarter last year. However, the recovery came amidst a concerning 23.04% sequential revenue decline, raising questions about the sustainability of the company's operational momentum. The stock, trading at ₹285.90 with a market capitalisation of ₹807.00 crores, has declined 19.97% over the past year, significantly underperforming both the Sensex and its specialty chemicals peer group.

View All News